https://www.selleckchem.com/pr....oducts/bgj398-nvp-bg
4) among carvedilol users (comparator arm) compared to corresponding to an adjusted hazard ratio (aHR) of 0.97 (95% confidence interval [CI] 0.94, 1.01). Similarly, metoprolol was not associated with a significant increase in the risk of secondary outcomes including insulin initiation aHR of 0.98 (95% CI 0.93, 1.04) and severe hyperglycemic events aHR of 0.98 (95% CI 0.93, 1.02). In this large study of older adults with HF and diabetes, initiation of metoprolol compared to carvedilol was not associated with an increase in the